Methocarbamol
NDC 87063-689, methocarbamol, tablet, from ASCLEMED USA INC..
- Product NDC
- 87063-689
- Status
- Listed
- Labeler
- ASCLEMED USA INC.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA040489
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/87063-689 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- METHOCARBAMOL750 mg/1
Pharmacologic classes
Centrally-mediated Muscle Relaxation [PE]; Muscle Relaxant [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 87063-689-12 | 87063068912 | 120 TABLET in 1 BOTTLE (87063-689-12) |
| 87063-689-30 | 87063068930 | 30 TABLET in 1 BOTTLE (87063-689-30) |
| 87063-689-60 | 87063068960 | 60 TABLET in 1 BOTTLE (87063-689-60) |
| 87063-689-90 | 87063068990 | 90 TABLET in 1 BOTTLE (87063-689-90) |
Linked data
RxNorm, label and prices
RxNorm concepts
RxNorm links no concept to this product's packages.
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 87063-689 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/87063-689 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 87063-689. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.